To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20
Completed
Parent Project, Italy
Phase 1
2011-10-01
This study will evaluate the pharmacokinetics plasma profile of 3 treatments: ISO 20, IBU 200
and IBU and ISO combinations (200 +20) given in single dose.
This study is being conducted to support the submission for new indication in treatment of
the combinations of Isosorbide Dinitrate and Ibuprofen as a treatment for Duchenne muscular
dystrophy.
Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina
Completed
Pfizer
Phase 4
2001-04-01
The objective of study is to compare the anti-ischemic efficacy and safety profiles of once
daily amlodipine or isosorbide-5-mononitrate in the treatment of stable asymptomatic and
symptomatic myocardial ischemia
Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina
Completed
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 4
2001-04-01
The objective of study is to compare the anti-ischemic efficacy and safety profiles of once
daily amlodipine or isosorbide-5-mononitrate in the treatment of stable asymptomatic and
symptomatic myocardial ischemia
Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes
Completed
Diabetes Australia
N/A
2002-10-01
The purpose of this project is to determine whether glucose metabolism can be improved by
administering a substance (nitric oxide donor) normally released by muscles during exercise.
Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes
Completed
Hoffmann-La Roche
N/A
2002-10-01
The purpose of this project is to determine whether glucose metabolism can be improved by
administering a substance (nitric oxide donor) normally released by muscles during exercise.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
